| The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers (NCT05483374) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-31 |
| Survival With Patients Treated With Salivary Gland Cancer (NCT05390294) | Clinical Center of Vojvodina | 2022-01-01 |
| 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma (NCT05010629) | Glenn J. Hanna | 2021-09-17 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas (NCT04620187) | Dana-Farber Cancer Institute | 2020-12-24 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers (NCT04209660) | Memorial Sloan Kettering Cancer Center | 2020-06-02 |
| Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients (NCT04291300) | Radboud University Medical Center | 2020-05-26 |
| Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) (NCT05694819) | National Cancer Center Hospital East | 2020-04-17 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| APG-115 in Salivary Gland Cancer Trial (NCT03781986) | University of Michigan Rogel Cancer Center | 2019-10-28 |
| Cabozantinib in Advanced Salivary Gland Cancer Patients (NCT03729297) | Radboud University Medical Center | 2018-09-05 |
| Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors (NCT03360890) | University of Chicago | 2018-03-26 |
| PSMA-PET Imaging for Advanced ACC/SDC (NCT03319641) | Radboud University Medical Center | 2017-10-25 |
| Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer (NCT03172624) | Memorial Sloan Kettering Cancer Center | 2017-05-26 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Androgen Deprivation Therapy in Advanced Salivary Gland Cancer (NCT01969578) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-09-24 |
| Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis (NCT02401763) | National Taiwan University Hospital | 2015-04-01 |
| A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes (NCT02069730) | University Health Network, Toronto | 2014-06-01 |
| Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study (NCT05008237) | Samsung Medical Center | 2014-05-02 |
| Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer (NCT02048254) | Peking University | 2014-02-01 |
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (NCT02042885) | Otsuka Novel Products GmbH | 2014-01-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Activity of Sorafenib in Salivary Gland Cancer (NCT01703455) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-09-01 |
| Stereotactic Body Radiotherapy for Head and Neck Tumors (NCT01344356) | Mercy Research | 2008-07-01 |
| A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (NCT00886132) | University Health Network, Toronto | 2007-01-01 |
| Iressa Study in Patients With Salivary Gland Cancer (NCT00509002) | M.D. Anderson Cancer Center | 2004-05-01 |